S&P 500 7,551.81 −0.45%
Nasdaq 25,978.42 −0.01%
S&P/TSX 35,491.27 −0.26%
Apple 332.41 +0.32%
Nvidia 213.90 +0.82%
Microsoft 490.30 −1.37%
Shopify 181.77 +0.54%
Royal Bank 283.06 −0.40%
CAD/USD 0.7148 −0.47%
PRE-MKT · 08:25 ET
Market ClerkRecap
Thu Sep 17 · pre-market3 signals today312 insider buys this week · $295.5MCIRO short report next: Sep 30The week ahead

HBIO

HARVARD BIOSCIENCE INC
NASDAQ · TECHNOLOGY · LABORATORY ANALYTICAL INSTRUMENTS
7.97
−0.03 −0.38%
USD · close Sep 16

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $36.3MP/E DIV YIELD FCF YIELD -3.08%REV TTM $87.8M −1.1%NET INCOME −$10.4MNET DEBT $30.2M52W 3.80 – 8.20SEC XBRL · TTM TO Invalid Date

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose HBIO in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
No 13D or 13G filing on HBIO in the last two years from the filings we read (13G only for companies we track; the sweep began Sep 2026).

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch HBIO. Know when insiders buy.
One email the day a filing lands. Free.